Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Latex immunotherapy: state of the art.

Nettis E, Delle Donne P, Di Leo E, Fantini P, Passalacqua G, Bernardini R, Canonica GW, Ferrannini A, Vacca A.

Ann Allergy Asthma Immunol. 2012 Sep;109(3):160-5. doi: 10.1016/j.anai.2012.07.004. Epub 2012 Jul 25. Review.

PMID:
22920069
2.

Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.

Bernardini R, Campodonico P, Burastero S, Azzari C, Novembre E, Pucci N, Massai C, De Martino M, Vierucci A.

Curr Med Res Opin. 2006 Aug;22(8):1515-22.

PMID:
16870076
3.

[New administration routes for immunotherapy].

Martorell Aragonés A.

Allergol Immunopathol (Madr). 2000 May-Jun;28(3):93-102. Review. Spanish.

PMID:
10867377
4.

Component-resolved immunologic modifications, efficacy, and tolerance of latex sublingual immunotherapy in children.

Lasa Luaces EM, Tabar Purroy AI, García Figueroa BE, Anda Apiñaniz M, Sanz Laruga ML, Raulf-Heimsoth M, Barber Hernández D.

Ann Allergy Asthma Immunol. 2012 May;108(5):367-72. doi: 10.1016/j.anai.2012.03.005. Epub 2012 Mar 30.

PMID:
22541410
5.

Efficacy and safety of sublingual immunotherapy.

Passalacqua G, Guerra L, Pasquali M, Lombardi C, Canonica GW.

Ann Allergy Asthma Immunol. 2004 Jul;93(1):3-12; quiz 12-3, 103. Review.

PMID:
15281466
6.

Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study.

Nettis E, Colanardi MC, Soccio AL, Marcandrea M, Pinto L, Ferrannini A, Tursi A, Vacca A.

Br J Dermatol. 2007 Apr;156(4):674-81.

PMID:
17493066
7.

Randomized, double-blind, placebo-controlled clinical trial of sublingual immunotherapy in natural rubber latex allergic patients.

Gastaminza G, Algorta J, Uriel O, Audicana MT, Fernandez E, Sanz ML, Muñoz D.

Trials. 2011 Aug 9;12:191. doi: 10.1186/1745-6215-12-191.

8.

The safety of a novel sublingual rush induction phase for latex desensitization.

Nettis E, Di Leo E, Calogiuri G, Milani M, Delle Donne P, Ferrannini A, Vacca A.

Curr Med Res Opin. 2010 Aug;26(8):1855-9. doi: 10.1185/03007995.2010.490671.

PMID:
20521869
9.

Sublingual immunotherapy for latex allergy: tolerability and safety profile of rush build-up phase.

Nucera E, Schiavino D, Sabato V, Colagiovanni A, Pecora V, Rizzi A, Aruanno A, Milani M, Pollastrini E, Patriarca G.

Curr Med Res Opin. 2008 Apr;24(4):1147-54. doi: 10.1185/030079908X291903 . Epub 2008 Mar 10.

PMID:
18334054
10.

[Perspectives in the treatment of allergy to latex: immunotherapy].

Tabar AI, Gómez B, Arroabarren E, Rodríguez M, Lázaro I, Anda M.

An Sist Sanit Navar. 2003;26 Suppl 2:97-102. Review. Spanish.

PMID:
13679968
11.

Latex sublingual immunotherapy: can its safety be predicted?

Buyukozturk S, Gelincik A, Ozşeker F, Colakoğlu B, Dal M.

Ann Allergy Asthma Immunol. 2010 Apr;104(4):339-42. doi: 10.1016/j.anai.2010.01.014.

PMID:
20408345
12.

New applications for sublingual immunotherapy in allergy.

Incorvaia C, Mauro M, Cappelletti T, Pravettoni C, Leo G, Riario-Sforza GG.

Recent Pat Inflamm Allergy Drug Discov. 2009 Jun;3(2):113-7.

PMID:
19519587
13.

[Treatment perspectives: immunotherapy with latex].

Tabar AI, Anda M, Gómez B, García B, Lizaso MT, Echechipía S, Arroabarren E, Olaguibel JM.

Allergol Immunopathol (Madr). 2002 May-Jun;30(3):163-70. Review. Spanish.

PMID:
11988148
14.

Priming-like effect and successful desensitization after anaphylactic shock by latex sublingual immunotherapy.

Antico A, Pagani M, Crema A.

Eur Ann Allergy Clin Immunol. 2007 Oct;39(8):259-61.

PMID:
18237003
15.

Natural rubber latex allergy in children: clinical and immunological effects of 3-years sublingual immunotherapy.

Bernardini R, Pecora S, Milani M, Burastero SE.

Eur Ann Allergy Clin Immunol. 2008 Dec;40(4):142-7.

PMID:
19227650
16.

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, Canonica GW.

Ann Allergy Asthma Immunol. 2006 Aug;97(2):141-8.

PMID:
16937742
17.

Oral and sublingual immunotherapy in paediatric patients.

Passalacqua G, Baena-Cagnani CE, Berardi M, Canonica GW.

Curr Opin Allergy Clin Immunol. 2003 Apr;3(2):139-45. Review.

PMID:
12750611
18.

Systematic reviews of sublingual immunotherapy (SLIT).

Radulovic S, Wilson D, Calderon M, Durham S.

Allergy. 2011 Jun;66(6):740-52. doi: 10.1111/j.1398-9995.2011.02583.x. Epub 2011 Mar 28. Review.

19.

Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.

Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P.

Allergy. 2012 Mar;67(3):302-11. doi: 10.1111/j.1398-9995.2011.02761.x. Epub 2011 Dec 12. Review.

20.

Kinetics and dynamic evaluation of specific immunotherapy.

Pereira C, Botelho F, Tavares B, Lourenço C, Baeta C, Palma-Carlos AG, Lima J, Chieira C.

Eur Ann Allergy Clin Immunol. 2004 Dec;36(10):375-86.

PMID:
15662966

Supplemental Content

Support Center